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Abstract

NIH-PA Author Manuscript

Proton beam radiotherapy is an effective and non-invasive treatment for uveal melanoma. Recent
research efforts have focused on improving the dosimetric accuracy of treatment planning and
overcoming the present limitation of relative analytical dose calculations. Monte Carlo algorithms
have been shown to accurately predict dose per monitor unit (D/MU) values, but this has yet to be
shown for analytical algorithms dedicated to ocular proton therapy, which are typically less
computationally expensive than Monte Carlo algorithms. The objective of this study was to
determine if an analytical method could predict absolute dose distributions and D/MU values for a
variety of treatment fields like those used in ocular proton therapy. To accomplish this objective,
we used a previously validated Monte Carlo model of an ocular nozzle to develop an analytical
algorithm to predict three-dimensional distributions of D/MU values from pristine Bragg peaks
and therapeutically useful spread-out Bragg peaks (SOBPs). Results demonstrated generally good
agreement between the analytical and Monte Carlo absolute dose calculations. While agreement in
the proximal region decreased for beams with less penetrating Bragg peaks compared with the
open-beam condition, the difference was shown to be largely attributable to edge-scattered
protons. A method for including this effect in any future analytical algorithm was proposed.
Comparisons of D/MU values showed typical agreement to within 0.5%. We conclude that
analytical algorithms can be employed to accurately predict absolute proton dose distributions
delivered by an ocular nozzle.

1. Introduction
Proton beam radiotherapy provides an effective, non-invasive treatment of uveal melanoma.
The local control is 94.8% at 10 years following treatment (Egger et al 2001). In many
cases, the therapy affords preservation of the organ and useful vision (Gragoudas and Marie
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Lane 2005, Munzenrider 2001). Recent research efforts have focused on improving the
dosimetric accuracy of treatment planning and delivery (Herault et al 2005, Koch and
Newhauser 2005, Newhauser et al 2002a). While pencil-beam algorithms have been
developed for dose calculations of large-field proton beams for the treatment of a variety of
sites (cf Hong et al 1996), treatment planning systems and algorithms for ocular proton
therapy are highly specialized (Goitein and Miller 1983, Koch 2006, Koch et al 2006,
Pfeiffer and Bendl 2001, Rethfeldt et al 2006, Sheen 2003). The pioneering work performed
at the Harvard Cyclotron Laboratory yielded the first such system, EYEPLAN, which
remains in widespread use today (Goitein and Miller 1983). However, Koch and Newhauser
(2005) highlighted the need for dose calculations of increased accuracy. They reported on
differences between EYEPLAN’s predicted relative dose distributions that differed from
Monte Carlo (MC) calculations by up to 12% of the maximum dose or up to 30% of the
local dose at shallow depths. Differences in the lateral beam penumbra were also presented.
Rethfeldt et al (2006) incorporated several improvements to analytical ocular treatment
planning including CT-based anatomical modeling, effects of tissue density variation and
lateral widening of the beam due to wedges and tissue. Others have demonstrated the ability
to overcome the limitation in accuracy associated with analytical dose algorithms by
reporting on proof-of-principal studies that utilized the MC method (Herault et al 2007,
Koch et al 2008, Newhauser et al 2005). A recent MC study revealed that the role of lowenergy protons, e.g. protons scattered into the treatment field at the edges of collimator
system, may be important (Titt et al 2008) in accurately predicting dose distributions in
patient anatomy but may be difficult to model analytically. For these reasons, it was unclear
whether an analytical dose algorithm would be able to predict dose distributions for ocular
proton therapy with accuracy comparable to that of MC simulations, i.e. to within 3% (dose
difference) or 0.05 cm distance-to-agreement (Koch et al 2008).
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Similarly, another limitation of previously described analytical algorithms is that they do not
predict the dose per monitor unit (D/MU) values, a common feature of algorithms for
photons and electron beams. Recently, several promising approaches for predicting D/MU
values were reported. D/MU predictions accurate to within 3% were reported by Kooy et al
(2003) using an analytical algorithm developed for proton fields with a large cross-sectional
area and deep penetration range. Herault et al (2007) reported a MC technique to predict
D/MU values to within 2% for spread-out Bragg peaks (SOBPs) for collimator diameters
between 0.75 and 3.4 cm. Koch et al (2008) demonstrated a MC approach to predict
absolute absorbed dose distributions in the eye and in periocular structures. However, in
clinical practice, it would be desirable to have two separate approaches to predict D/MU
values, i.e. a primary method of D/MU calculation provided by the treatment planning
system, and a secondary independent method such as measurement (Newhauser et al 2002b)
or Monte Carlo calculations. As described here, MC algorithms have been shown to
accurately predict D/MU values, but this has yet to be shown for analytical algorithms used
in treatment planning systems dedicated to ocular proton therapy. MC calculations may also
consume considerably more computational resources than analytical algorithms (Koch et al
2008), demonstrating the need for an accurate analytical algorithm.
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The objective of this study was to determine if analytical methods could predict D/MU
values at the center of an SOBP to within 0.5% of measured values for a variety of treatment
fields relevant to ocular proton therapy. To accomplish this objective, we used a MC model
of the ocular nozzle designed at Harvard Cyclotron Laboratory to develop an algorithm to
predict three-dimensional (3D) distributions of D/MU from pristine Bragg peaks and
therapeutically useful SOBPs. The accuracy of the MC model was previously verified with
measured data and is used extensively here to provide data for the beam modeling as well as
for comparison (Koch et al 2008). The MC model, the analytical algorithm presented here
and their results are described further by Koch (2006).

2. Methods
2.1. Analytical algorithm to predict absorbed dose
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In this section we describe an analytical dose algorithm, we refer to as EYEDOSE, that aims
to predict relative proton dose distributions within ±3% and ±0.05 cm and absolute D/MU
values within ±0.5% of measured values. The notable features of EYEDOSE are explicit
modeling of the influence of edge-scattered protons on the cross-field shape, the effect of
energy straggling in the distal portion of poly-energetic beams and modeling of absolute
D/MU values.
The absorbed dose per monitor unit at any point in the target, D(x, y, z)/MU, can be
calculated as the combination of two main terms, the central-axis dose term, D(z)/MU, and a
dimensionless off-axis modifier term, OAM(x, y, z), such that

(1)

The coordinates (x, y, z) describe the location of the point of interest relative to the effective
source location. That is, the point of interest is expressed in the source coordinate system
whose origin lies at the effective source location. The +z-axis is aligned to the central axis of
the beam and is directed toward the patient. The +x- and +y-axes are directed to the patient’s
right and superiorly, respectively, as the patient looks upstream from isocenter in the seated
treatment position.
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The basic approach of equation (1) has been used in the pencil-beam algorithms reported by
Hogstrom et al (1984) for electrons and by Hong et al (1996) for protons; many of the
unique parameters of the EYEDOSE broad-beam algorithm developed here were additions
or modifications to the broad-beam algorithm described in the latter study.
Range modulation is important in modeling clinical proton beams and was accomplished by
summing the dose contributions from individual Bragg peaks. Applying this principle to
equation (1) we obtain
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where N is the total number of range modulation steps, with each corresponding to the ith
step of the range modulator wheel.
Each term in equation (2) is calculated as a combination of many other terms such that D(z)
is calculated by

(3)

and OAM(x, y, z) is calculated by

(4)
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The terms on the right-hand side of the central-axis dose equation and off-axis modifier in
equations (3) and (4), respectively, attempt to model changes in the proton beam that occur
for a variety of beam modifiers and depths in the target. More detailed descriptions of each
term presented are defined later. Substituting equations (3) and (4) into equation (2) yields
the general dose equation for a modulated proton beam as

(5)

within the target. Note that the D(z) and OAM(x, y, z) terms can be separated because of
their nearly complete independence from one another. Therefore, they will be discussed
separately beginning first with D(z) as it appears in equation (3), to be followed immediately
by descriptions of the terms in equation (4).
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2.1.1. Depth-dose profile, DD, and effective depth, deff—In the simplest case, the
first term of equation (3), DD(d), is the absolute absorbed dose profile along the beam’s
central axis, in units of cGy/MU, which varies along the water-equivalent depth, d, in the
target. This depth-dose profile is unique because it is acquired when the nozzle is free of all
beam-modifying devices except those that are always present in the beam, such as the
monitor chambers and beam scattering system. This elementary state of the nozzle is
referred to as the ‘open-beam condition’ and the pristine Bragg peak shape in this state is
referred to as the ‘open-beam depth-dose profile’. By default, this is the most penetrating
beam the nozzle is capable of delivering. The beam range, R90, is defined as the distal depth
in water at which the central-axis dose value falls to 90% of its maximum. As considered
here, the SSD was fixed. This treatment setup was in keeping with the practice when using
the Harvard Cyclotron Laboratories ocular treatment nozzle, which was considered in this
work. The treatment setup for other institutions may vary.
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As beam-modifying material is inserted into the beam’s path, the profile described by DD(d)
is shifted upstream within the target by the water-equivalent thickness of the additional
upstream material. With this shift, the dose at any point along the profile is determined at an
effective depth, deff, which includes the range loss due to any additional beam-modifying
material upstream. Specifically, deff is equal to the accumulation of the range loss in water
due to energy losses in the range modulator wheel, variable degrader, and patient or water
phantom and is used to lookup the value along the DD profile:
(6)

Range loss in water due to the modulator step is given by

(7)
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where T is the physical modulator step thickness; ρmod and ρw are the mass densities of the
range modulator material (polymethyl methacrylate (PMMA)) and water, respectively; and
the final term is the ratio of mean mass stopping powers of PMMA to water (Newhauser et
al 2002c). Because the ratio of the mass stopping powers was only slightly dependent on
energy, a constant value of 0.976 for PMMA was used, similar to the approach taken by
Hong et al (1996). A theoretical basis for this approximation was recently derived by Zhang
and Newhauser (2009).
In contrast, the range loss in water due to the variable degrader, rdeg, was conveniently
determined from the difference between the deepest penetrating Bragg peak of interest and
the penetration depth of the open-beam depth-dose profile, i.e. the range loss in the variable
degrader is not calculated similar to rmod using equation (7). Because the phantom and eye
model are water equivalent, the range loss that occurred in the patient, rpat, is equal to the
product of the number of the voxels upstream from the point of interest to the surface and
the voxel thickness. Thus, DD (deff) is an important contributor to the calculation of
absorbed dose in EYEDOSE.
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2.1.2. Range modulator wheel fluence weighting factor, ωRMW—To create a
modulated beam, several pristine Bragg peaks of various ranges are superimposed.
Therefore, the dose at any point is the sum of the dose to that point from shifted Bragg peaks
created by the increasing step thicknesses of the range modulator wheel. The total opening
angle of each step thickness per revolution of the range modulator wheel determines the
fluence weighting factor ωRMW. That is, the fluence weighting factor reflects the fraction of
the total fluence incident upon each modulation step. Thus, the summation of a modulated
beam is described by equation (5) where ωRMW considers the fluence weight of the ith range
modulator wheel step, the design of which is an input parameter for the algorithm. In
addition, multiple Coulomb scattering within the range modulator wheel reduces the fluence
of the beam, and this was parameterized separately, as described below.
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2.1.3. Scatter and attenuation fluence weighting factor, ωSAF—As the initial
proton beam is degraded by the range shifter and range modulator wheel, multiple Coulomb
scattering and nuclear interactions within these components reduce the proton fluence and
produce a shift in the effective source location. In order to take into account these effects, an
empirically deduced proton fluence correction factor, ωSAF, was introduced. The fluence
reductions strongly influenced the D/MU values for this nozzle design because the monitor
chambers were located in close proximity to the effective source.
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The central purpose of ωSAF is to parameterize the decrease in the D/MU value of the Bragg
peak as a function of decreasing beam range. The beam range at the surface of the patient
may be reduced by the range modulator wheel or variable degrader. For the nozzle design
studied here, the initial beam energy at the nozzle entrance is 159 MeV, but a fixed degrader
reduces the energy to a more clinically useful 70 MeV. This energy degradation is also the
dominant source of beam spreading, making the lateral spread of the beam insensitive to the
location of additional modulating material. Therefore, changes to the beam range were
accomplished using the variable degrader. This fluence weighting factor was deduced by
plotting MC simulation results of the peak D/MU value for beams of several arbitrary
residual ranges, Darb, normalized to the peak D/MU value of the open beam, Dopen, as given
by

(8)
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Thus, by definition ωSAF is unity for the open-beam condition. Note that the aperture size
was kept constant in the calculations of Darb and Dopen. Adding beam-modifying material
upstream causes increased scattering and fluence losses, and therefore shallower beams have
ωSAF values less than unity. Furthermore, adding material upstream results in a decreased
beam range, so the depth of the Bragg curve peak, where Darb was determined, is shallower
and closer to the source. However, by our definition, ωSAF specifically excludes changes in
D/MU for a Bragg peak that has shifted upstream due to the inverse square law effect, which
is taken into account separately. Therefore, the inverse square effect present in Darb needs to
be removed for the proper parameterization of ωSAF. To that end, the value given above for
Darb is actually the peak D/MU value after having removed the inverse square effect by
multiplying the raw MC-calculated peak D/MU, D′arb value by the reciprocal of an inverse
square term. That is,

(9)

where darb is the depth in water of the Bragg peak where the value of D′arb is calculated.
Similarly, dopen is the depth in water where Dopen is calculated, and SSD is distance from
the effective source position of the open beam to the phantom surface. Then ωSAF was
parameterized using a third-order polynomial fit of its value as a function of R90 for six
simulated pristine Bragg peaks with ranges from 0.7 cm to 4.0 cm.
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The scatter and attenuation fluence weighting factor values were determined using a
constant value of SSD, regardless of the change in effective source position as a function of
energy degradation. Therefore, to a first order, ωSAF implicitly takes into account the effect
of variations in the effective source position that occur for beam ranges other than those
yielded by an open beam.
2.1.4. Inverse square correction—The last physical effect on the fluence along the zaxis that we shall consider is a correction for inverse square law reductions in the proton
absorbed dose. This correction considers the increase in the peak D/MU of the Bragg curve
as it is shifted upstream solely because it is closer to the effective source position and is
given as

(10)
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where SSD is the distance from the effective source position to the phantom surface
calculated under the open-beam condition, deff is the effective depth as given by equation (6)
and z is the distance from the effective source to the point of interest.
Now, all the terms listed in equation (3) have been described, and the focus will now shift to
describing the terms in equation (4) that consider the dose at off-axis locations.
2.1.5. Collimation modifier, Γ—The proton beam undergoes multiple Coulomb
scattering in the range modulator wheel, variable degrader, fixed degrader and patient. The
scattering increases the Gaussian width, or lateral spread, of the beam, thus increasing the
width of the lateral dose falloff region (Gottschalk et al 1993). In practice, the patientspecific collimating aperture provides a rapid lateral falloff of dose. In the present study, the
collimator was modeled as an infinitely thin slab that stopped all particles incident upon it.
The lateral dose falloff, or penumbra, was modeled by the convolution of the Gaussian beam
profile over a Heaviside step function. Mathematically, this calculation reduces the off-axis
term, Γ, to the evaluation of an error function,

NIH-PA Author Manuscript

(11)

where σtot is the 1−σ width of the Gaussian beam profile at the point of interest, β is defined
as the lateral distance between a ray cast from the effective source location to the point of
interest and another ray through the collimator’s edge from the effective source location
projected to the z-position of the point of interest. This is calculated using the following
equation:
(12)

and is illustrated schematically in figure 1.
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The value of σtot is determined by adding σsrc and σpat in quadrature according to
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(13)

where z is the distance from the effective source of the open beam to the point of interest in
the patient, zbld is the distance from the effective source of the open beam to the beamlimiting device, i.e. the aperture. The value of σpat considers the lateral spreading of the
beam due to scatter in the patient. The value of σsrc is the quadrature sum of the transverse
beam widths in the inherent open-beam size, σopen, the scatter in the range modulator wheel,
σmod, and variable degrader, σdeg,

(14)
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Note that σopen inherently includes the scatter contribution from the fixed degrader and other
nozzle components always present in the beam. Therefore, σtot ≥ σopen in all cases since the
addition of more material into the beam acts only to add more transverse beam width to the
open-beam condition. Further, because the multiple Coulomb scattering within the fixed
degrader of the Harvard Cyclotron Laboratory ocular nozzle dominates the Gaussian profile
of the open beam as observed at the nozzle exit, σopen is considered axially symmetric as it
enters the nozzle (Koch et al 2008). The analytical calculations of the contributions to the
Gaussian beam width contained in σmod and σdeg were described by Gottschalk et al (1993).
The calculation of σpat was taken from Hong et al (1996) where after numerical integration
the transverse beam size as a function of R90 is given as

(15)

Here, the value of σpat must be computed for the individual Bragg peaks that comprise the
SOBP, so R90 depends on the range of the ith beam over the summation in equation (5).
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More detailed descriptions of the calculations of σmod, σdeg and σpat have been described
excellently by Gottschalk et al (1993) and Hong et al (1996). For this work, the calculations
presented by Hong et al were adopted and tabulated for quick lookup during the calculations
of this algorithm.
2.1.6. Off-axis ratio, OAR—The collimation modifier described above models changes in
the lateral beam penumbra width, whereas the off-axis ratio, OAR, models change in the
lateral beam profile within the high-dose region of the beam. This uncollimated lateral beam
profile was modeled by a Gaussian function normalized to unity on the central axis. The
width of this Gaussian increased with depth in the patient due to multiple Coulomb
scattering (Gottschalk et al 1993) and geometric magnification of the accumulated
transverse widths, e.g. σsrc. The OAR models these effects as a function of the residual
range and off-axis distance. Previous analytical algorithms have ignored one or both of these
dependences. Hong et al considered a similar factor at one depth and referred to it the crossPhys Med Biol. Author manuscript; available in PMC 2014 August 15.
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field intensity profile. In EYEPLAN (Sheen 2003), a widely used broad-beam algorithm, all
off-axis dependences of the cross-field intensity are neglected and the high-dose region of
the SOBP is approximated as being uniformly flat. These assumptions slightly limit the
accuracy of those algorithms in predicting cross-field dose profiles. Therefore, a key
distinction between EYEDOSE and this previous work is the parameterization of these
dependences using a Gaussian function such as

(16)

where r is the radial distance to the central axis and σΨ characterizes the Gaussian width of
the beam profile as a function of the reduced range, which is described below.
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The OAR term requires the parameterization of σΨ as a function of depth, d, which
implicitly takes into account the influence of edge-scattered protons and multiple Coulomb
scattering in the patient relative to the central-axis dose given by equation (3). However, the
reader should be cautioned that the OAR term does not model edge-scattered protons in
depth, the importance of which will be shown in section 3.2 later. To determine σΨ at
arbitrary depths, a Gaussian curve was fit to the normalized cross-field profiles of the four
unmodulated beams considered in this work, beginning at the water phantom surface to a
depth of 4.5 cm in 0.25 cm increments. A plot of the Gaussian widths, σ, as a function of the
reduced range shown in figure 2 illustrates that the change in field flatness width depth was
very similar among the four pristine beams. Recall that the reduced range is the waterequivalent depth in the target divided by the initial range of the proton beam at the phantom
surface, i.e. d/R90. A fourth-order spline fit to the open beam was used in this work to
demonstrate the accuracy achievable by EYEDOSE while relying on the most elementary
beam condition as much as possible. The spline fit provided the means to calculate σΨ for
arbitrary depths in the target. Though in practice, a two-dimensional (2D) lookup table of
OAR as a function of r and reduced range, as shown graphically in figure 3, was compiled at
the dose grid resolution used to facilitate quick lookup during calculations.
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Following the above description of the off-axis ratio in equation (16), the description for the
analytical calculation of dose at any point in a modulated proton beam, as given by equation
(5), is complete. For brevity, the simulation and analysis of additional data needed to
configure EYEDOSE are found in the appendix.
2.2. Measurements and MC calculations
Measurements were performed to benchmark the MC model used to develop and validate
the analytical dose algorithm. The measurements included dose profiles and absolute dose
values under several combinations of beam penetration ranges and range-modulation widths
using a plane-parallel ionization chamber. Cross-field profiles were taken at several waterequivalent depths on radiochromic film (Type Gafchromic EBT, ISP Corp.).
All measurements and calculations were performed with a final collimator aperture diameter
of 2.4 cm. Table 1 lists the eight combinations of penetration ranges and modulation widths
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considered in this work. For quick reference, each combination was given a unique beam
label. For example, the open beam spoken of above will be referred to as the 4000 beam,
according to the labeling given in this table. Also listed in the table are the water-equivalent
depths at which the D/MU measurements were taken (Newhauser et al 2002b). To obtain the
D/MU value at the maximum of each pristine Bragg peak, we measured D/MU at a waterequivalent depth of 0.9 cm and divided by the respective local percent depth dose value. For
details of this and the other measurements and MC calculations, the reader is referred to
Koch et al (2008).

3. Results
In this section, the results from MC simulations used to generate the needed data for the
development and configuration of the algorithm are presented first. Those results are
followed by a comparison of profiles from analytical calculations and previously published
MC simulations, and when available ionization chamber and film measurements for
corroboration. The accuracy of the MC model was described previously (Koch et al 2008).
3.1. Comparisons of dose calculations in a water phantom

NIH-PA Author Manuscript

3.1.1. Depth-dose profiles—Figure 4 shows the measured and calculated profiles, by
MC and EYEDOSE, for the 1500 and 4000 beams, in a flat-surfaced water phantom. The
analytically calculated profile of the 4000 beam shown here agreed with its MC counterpart
to within 0.1% of the MC-calculated peak D/MU value. Recall this depth-dose profile, under
the open-beam condition, served as the central-axis profile for lookup during analytical
calculations. Therefore, the analytically calculated profile of the 4000 beam shown here
demonstrates the correct configuration of the central-axis data. Similarly, the analytically
calculated profile of the 1500 beam agreed with its MC counterpart to within −4.1% of the
MC-calculated peak D/MU value near the surface but was within 0.3% near the peak. The
phenomenon of increasing differences at shallow depths with decreasing range is described
more in section 3.2, and, as will be shown below, appears to some extent in the comparison
of the SOBPs.
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More clinically relevant comparisons are shown in figure 5 for all four SOBPs considered in
this work. The MC and ionization measurements shown were adopted from Koch et al
(2008). Overall, these analytically calculated profiles agreed with their corresponding MC
profiles to within 5%. Except for the 2020 beam shown in figure 5(b), the largest
discrepancy for each SOBP occurred near the phantom surface. Note that agreement beyond
a depth of 0.7 cm was within 2% (figures 5(a), (c), (d)).
It is worth noting that the 2020 beam shown in figure 5(b) represented a unique
circumstance for the algorithm. As demonstrated by the ionization chamber measurement,
and confirmed by the MC calculation, the plateau region of this fully modulated SOBP
decreased distally with respect to the analytical calculation. The underestimated distal region
of the plateau can be partially attributed to the range modulator wheel design, which was
actually designed for a beam with greater range, i.e. 2.1 cm of range and modulation instead
of 2.0 cm presented here.

Phys Med Biol. Author manuscript; available in PMC 2014 August 15.
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Table 2 shows additional characteristics of all depth-dose profiles in this work from the MC
and analytical calculations. All differences in the comparison are within 0.05 cm except for
the fully modulated 2020 and 3030 beams.
3.1.2. Cross-field comparisons—Comparison of the cross-field profiles calculated by
the analytical algorithm showed excellent agreement with MC results at several depths for
all beams in both the geometric expansion of the beam and the shape of the high-dose lowgradient regions. Figure 6 shows two cross-field profiles at depths of 0.5 cm and 2.4 cm for
the 3015 beam. Each profile has been normalized to the central-axis dose to highlight the
change in the flatness and penumbra with depth. Recall that the algorithm specifically
attempts to model change in the flatness of the low-gradient regions as a function of off-axis
distance and reduced range (see section 2.1.6). Table 3 shows the cross-field widths at
several water-equivalent depths, d.
3.1.3. Comparison of absolute D/MU values—Dose per monitor unit values in a
water phantom was calculated both analytically and by MC (table 1). All D/MU values from
EYEDOSE agreed with MC calculations to within 0.5% with one exception, the 2020 beam.
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3.1.4. Two-dimensional gamma analysis—Gamma analysis using criteria of 3% dose
and 0.05 cm was performed on corresponding data for each beam configuration listed in
table 1, for both the flat-surfaced water phantom and eye model geometries (Low et al
1998). The criteria were chosen based on typical percentage difference tolerated in dose
plane comparisons used for quality assurance and limitations imposed by the voxel
dimensions in the MC and analytical calculations. Figure 7 shows results for all beams on
the flat-surfaced water phantom and gives an overview of the agreement between
EYEDOSE calculations and corresponding MC calculations. The shade of gray darkens as
the gamma value increases. Locations within the beam where the criteria were not met
resulted in gamma values exceeding 1 (shown as solid black). Overlaid onto the 2D gamma
distributions in figure 7 are the 20%, 50%, and 90% isodose lines calculated by EYEDOSE.
As observed in the central-axis depth-dose profiles above, EYEDOSE calculations tended to
disagree with MC calculations in the proximal portion of the beam, more so as the beam
range decreased or as the relative fluence weight of less-penetrating beams increased for an
SOBP. The likely source for this disagreement is described in section 3.2 below.
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3.2. Effect of edge-scattered protons
As illustrated in figures 4 and 7, the EYEDOSE algorithm underestimated the dose near the
phantom surface. The observed differences increased with decreasing beam range, e.g. up to
5% for the 1500 beam. It was suspected that edge-scattered protons, largely ignored by this
and other analytical algorithms, may have been the source of the observed difference. To
investigate this possibility, we performed separate MC simulations identical to the previous
simulations that produced the 1500 and 4000 data shown in figure 4 except that the brass
collimating material that comprised the ocular nozzle model was given an importance equal
to zero. This effectively terminated the history of any simulated proton that interacted with
any collimating device, thus preventing protons from scattering downstream. The results of
these simulations are shown in figure 8.
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As described in section 2.1.1, EYEDOSE calculated the dose as a function of the effective
depth along the 4000 beam. This process led to a significant difference in the contribution to
the scattered portion of the beam at shallow depths relative to deeper depths as calculated by
MC. For example, as section 2.1.1 describes, the water-equivalent depth of 3.0 cm on the
4000 curve is equal to the effective depth, deff, of a point 0.5 cm deep along the 1500 curve
shown in figure 4. In examining figure 8, which also shows the 1500 and 4000 beams, it can
be observed that the non-scattered components of the 1500 and 4000 beams at 0.5 cm and
3.0 cm depths were similar and were equal to 61.5% and 62.8%, respectively. The relative
contributions of edge-scattered protons at this effective depth in the 1500 and 4000 beams
were 4.8% and 0.7%, respectively. Therefore, this example shows that the algorithm’s
referencing of an effective depth equal to 3.0 cm in the calculation of the 1500 beam will
neglect to account for almost 4.1% of the peak dose near the phantom surface.
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We explored a method by which future analytical algorithms may model the contribution of
edge-scattered protons. Figure 9 shows the relative dose contributions of edge-scattered
protons to the 1500 and 4000 beams plotted as a function of the reduced range. The
similarity of the data demonstrates that the edge-scattered component can be easily
separated from the rest of the beam for easy modeling to improve the algorithm’s dosimetric
accuracy in the proximal region. Future analytical algorithms may reference open-beam
depth-dose data that exclude edge-scattered protons. The important contribution of edgescattered protons can easily be added as a separate component of the beam.
3.3. Dose calculations and comparisons in an eye model
Figure 10 demonstrates EYEDOSE’s ability to calculate doses in a 3D customizable eye
model described previously (Koch et al 2008); shown here are two SOBPs considered in the
present work.
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Similar to the comparisons made in figure 7 for the flat-surfaced water phantom geometry,
figure 11 shows 2D comparisons of MC and EYEDOSE calculations of each beam on the
eye model, the outline of which has been omitted for clarity. Again, the comparison is made
by showing local gamma values calculated using a 3% dose difference and 0.05 cm distance
criteria. The best agreement was observed for the open beam (d). As the range was
decreased and range modulation increased, the agreement between EYEDOSE calculations
and the MC calculations broke down at the most proximal surface for the reason described
in section 3.2 above. In addition to this effect, the decreased agreement distal to the junction
of the curved eye surface and the flat surface demonstrated the limitation of the broad-beam
algorithm to precisely model side-scattered protons. This effect is most easily observed near
the Bragg peak and surface, e.g. where side-scattered protons are present; here, the mean
scattering angle increases sharply for low-energy protons.

4. Discussion
In this work we developed an analytical algorithm to predict absolute dose distributions and
demonstrated its accuracy by comparing its calculations to previously reported calculations
from a benchmarked MC model of an ocular nozzle for proton therapy. We found that the
predictions from the analytical algorithm agreed well with MC calculations. For depths
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greater than 0.7 cm the absorbed dose depth profiles agreed to within ±2% of the peak dose
for three of the four SOBPs considered. Typically, analytical and MC-calculated D/MU
values showed a maximum difference within 0.5% for pristine and range-modulated Bragg
peaks.
Newhauser et al (2007) have previously demonstrated the use of Monte Carlo as a tool for
evaluating the accuracy of a commercial pencil beam algorithm for proton therapy. Their
work allowed the preliminary testing of a new commercial treatment planning system ahead
of the acquisition of measured beam data, which was not possible due to the ongoing
construction of the treatment facility. The Monte Carlo model used for these simulations
was derived from detailed design drawings and specifications from the equipment vendor.
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Others have reported on analytical algorithms for dose calculations in the eye. A pioneering
analytical algorithm and its associated treatment planning system were first described by
Goitein and Miller (1983) and have since became known as EYEPLAN. Since its
introduction, others have contributed to the capabilities of the original planning system
(Sheen 1994), but it is still limited to relative dose predictions and the accuracy of its dose
predictions in the proximal region is limited by the simplicity of the algorithm (Koch and
Newhauser 2005). Another treatment planning system for proton therapy of the eye, referred
to as OCTOPUS, has been described by Pfieffer and Bendl (2001) and uses x-ray computed
tomography (CT) images upon which to base its eye model. Both EYEPLAN and
EYEDOSE currently base the eye model on a geometrical reconstruction on the eye using
ophthalmological measurements that characterize the eye’s shape and tumor location, so a
CT-based approach is unique. However, a detailed description of their algorithm and
comparisons to Monte Carlo or measured data is still forthcoming.
The analytical absolute dose calculations reported here are the most accurate yet for ocular
proton therapy. The broad-beam algorithm, which we have called EYEDOSE, is similar to
previous broad-beam algorithms, most notably that reported by Hong et al (1996). However,
EYEDOSE extends the capabilities of earlier approaches by including the modeling of a
depth-dependent intensity profile as well as fluence weighting factors; these allow
EYEDOSE to accurately predict absolute values of absorbed dose per monitor unit.
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Monte Carlo is increasingly becoming more than an evaluation tool and is instead being
developed to satisfy routine dose calculations in the clinic. Efforts toward this goal have
been described by others demonstrate the potential for accurate dose calculations based on
first principles of proton interactions with matter (Herault et al 2005, 2007, Koch et al
2008). To our knowledge, this technology has not yet been commercialized, though we
expect that it will be and eventually replace analytical algorithms.
A key strength of this work is inherent in our comparison of analytical calculations to MC
calculations. Since the MC model was previously benchmarked to measured data, using MC
provided the ability for a more robust comparison than otherwise could have been afforded
by measured data. For example, comparisons of depth-dose data could be made on a much
finer scale and include depths proximal to 0.9 cm, for which measured data were unavailable
due to the sidewall thickness of the water phantom (Koch et al 2008). This ability led to the
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discovery and demonstration of the important contributions of edge-scattered protons to
dose in the proximal region and demonstrated an easy method for including these
contributions in future analytical models. Last, our approach allowed for high-resolution
comparisons of 2D analytical and MC calculations, which would have been limited to a
lower resolution.
A limitation of this work is that calculations were only verified against measurements of a
circular field collimated with a 2.4 cm diameter aperture. As was true for Hong et al (1996),
we expect the reliability of the analytical algorithm to decrease for aperture sizes less than
1.0 cm. However, the typical field diameter used in ocular proton therapy is between 1.0 and
3.5 cm (Munzenrider 2001), suggesting that this limitation will be irrelevant in most
instances. Lastly, while the eye is a relatively homogeneous structure, dose calculations in
heterogeneous materials have not been evaluated.
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The high importance of considering edge-scattered protons in analytical calculations was
demonstrated by their significant effect on the level of agreement with Monte Carlo data
observed in the proximal region of the target. This is in agreement with the findings of Titt
et al (2008) who described the effects of collimator scattered protons on the D/MU and
proximal doses at higher beam energies for large-field proton therapy. As discussed in this
work, we believe this effect in ocular proton therapy can be fully modeled analytically to
improve the accuracy of analytical calculations.

5. Conclusion
The results of this study demonstrated that it is possible to predict D/MU values accurately
for clinically relevant range-modulated proton beams for ocular therapy using an analytical
dose algorithm. Detailed absolute dose comparisons of 2D dose plans showed that the
analytical model predicted the D/MU values within the stated criteria of 3% and 0.05 cm in
most cases. These results strongly support the feasibility of accurately predicting absolute
dose distributions in customizable patient geometry.
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The MC method provided crucial data that emphasized the important role of edge-scattered
protons in the accurate prediction of dose in the proximal region of pristine and spread-out
Bragg peaks. Using this method, analytical algorithms may be rigorously tested and further
enhanced by improved modeling of these effects that would be extremely difficult to
measure.

Acknowledgments
This work was funded in part by Varian Medical Systems, The Sam Taub and Beatrice Burton Endowed Fellowship
in Vision Disease, and Northern Illinois University through a subcontract of Department of Defense contract
W81XWH-08-1-0205. We wish to thank Kathryn Carnes for her help in revising this manuscript.

References
Egger E, Schalenbourg A, Zografos L, Bercher L, Boehringer T, Chamot L, Goitein G. Maximizing
local tumor control and survival after proton beam radiotherapy of uveal melanoma. Int J Radiat
Oncol Biol Phys. 2001; 51:138–47. [PubMed: 11516863]

Phys Med Biol. Author manuscript; available in PMC 2014 August 15.

Koch and Newhauser

Page 15

NIH-PA Author Manuscript
NIH-PA Author Manuscript
NIH-PA Author Manuscript

Goitein M, Miller T. Planning proton therapy of the eye. Med Phys. 1983; 10:275–83. [PubMed:
6308407]
Gottschalk B, Koehler A, Schneider R, Sisterson JM, Wagner M. Multiple Coulomb scattering of 160
MeV protons. Nucl Instrum Methods Phys Res. 1993; B74:467–90.
Gragoudas ES, Marie Lane A. Uveal melanoma: proton beam irradiation. Ophthalmol Clin North Am.
2005; 18:111–8. ix. [PubMed: 15763196]
Herault J, Iborra N, Serrano B, Chauvel P. Monte Carlo simulation of a protontherapy platform
devoted to ocular melanoma. Med Phys. 2005; 32:910–9. [PubMed: 15895573]
Herault J, Iborra N, Serrano B, Chauvel P. Spread-out Bragg peak and monitor units calculation with
the Monte Carlo Code MCNPX. Med Phys. 2007; 34:680–8. [PubMed: 17388186]
Hogstrom KR, Mills MD, Meyer JA, Palta JR, Mellenberg DE, Meoz RT, Fields RS. Dosimetric
evaluation of a pencil-beam algorithm for electrons employing a two-dimensional heterogeneity
correction. Int J Radiat Oncol Biol Phys. 1984; 10:561–9. [PubMed: 6725043]
Hong L, Goitein M, Bucciolini M, Comiskey R, Gottschalk B, Rosenthal S, Serago C, Urie M. A
pencil beam algorithm for proton dose calculations. Phys Med Biol. 1996; 41:1305–30. [PubMed:
8858722]
Koch, N. PhD Thesis. The University of Texas Health Science Center at Houston and The University
of Texas M D Anderson Cancer Center; Houston, TX: 2006. Monte Carlo and analytical dose
calculations for ocular proton therapy.
Koch, N.; Giebeler, A.; Newhauser, W. Customer evaluation testing: report for the protoneye
treatment planning software. M D Anderson Cancer Center; Houston, TX: 2006.
MDACC-10-0029
Koch N, Newhauser W. Virtual commissioning of a treatment planning system for proton therapy of
ocular cancers. Radiat Prot Dosim. 2005; 115:159–63.
Koch N, Newhauser WD, Titt U, Gombos D, Coombes K, Starkschall G. Monte Carlo calculations and
measurements of absorbed dose per monitor unit for the treatment of uveal melanoma with proton
therapy. Phys Med Biol. 2008; 53:1581–94. [PubMed: 18367789]
Kooy HM, Schaefer M, Rosenthal S, Bortfeld T. Monitor unit calculations for range-modulated
spread-out Bragg peak fields. Phys Med Biol. 2003; 48:2797–808. [PubMed: 14516102]
Low DA, Harms WB, Mutic S, Purdy JA. A technique for the quantitative evaluation of dose
distributions. Med Phys. 1998; 25:656–61. [PubMed: 9608475]
Munzenrider JE. Uveal melanomas. Conservation treatment. Hematol Oncol Clin North Am. 2001;
15:389–402. [PubMed: 11370500]
Newhauser W, Fontenot JD, Zheng Y, Polf JC, Titt U, Koch N, Zhang X, Mohan R. Monte Carlo
simulations for configuring and testing an analytical treatment planning system. Phys Med Biol.
2007; 52:4569–84. [PubMed: 17634651]
Newhauser W, Koch N, Hummel S, Ziegler M, Titt U. Monte Carlo simulations of a nozzle for the
treatment of ocular tumours with high-energy proton beams. Phys Med Biol. 2005; 50:5229–49.
[PubMed: 16264250]
Newhauser W, Titt U, Dexheimer D, Yan X, Nill S. Neutron shielding verification measurements and
simulations for a 235-MeV proton therapy center. Nucl Instrum Methods Phys Res. 2002a;
476:80–4.
Newhauser WD, Burns J, Smith AR. Dosimetry for ocular proton beam therapy at the Harvard
Cyclotron Laboratory based on the ICRU Report 59. Med Phys. 2002b; 29:1953–61. [PubMed:
12349914]
Newhauser WD, Myers KD, Rosenthal SJ, Smith AR. Proton beam dosimetry for radiosurgery:
implementation of the ICRU Report 59 at the Harvard Cyclotron Laboratory. Phys Med Biol.
2002c; 47:1369–89. [PubMed: 12030561]
Pfeiffer K, Bendl R. Real-time dose calculation and visualization for the proton therapy of ocular
tumours. Phys Med Biol. 2001; 46:671–86. [PubMed: 11277216]
Rethfeldt C, Fuchs H, Gardey KU. Dose distributions of a proton beam for eye tumor therapy: hybrid
pencil-beam ray-tracing calculations. Med Phys. 2006; 33:782–91. [PubMed: 16878580]
Sheen, M. Development of the EYE proton therapy planning program. XX PTCOG Meeting; Chester,
England. 1994. p. 29
Phys Med Biol. Author manuscript; available in PMC 2014 August 15.

Koch and Newhauser

Page 16

NIH-PA Author Manuscript

Sheen, M. EYEPLAN software user’s manual. 2003.
Titt U, Zheng Y, Vassiliev ON, Newhauser WD. Monte Carlo investigation of collimator scatter of
proton-therapy beams produced using the passive scattering method. Phys Med Biol. 2008;
53:487–504. [PubMed: 18185001]
Zhang R, Newhauser WD. Calculation of water equivalent thickness of materials of arbitrary density,
elemental composition and thickness in proton beam irradiation. Phys Med Biol. 2009; 54:1383–
95. [PubMed: 19218739]

Appendix
All configuration data for the EYEDOSE broad-beam algorithm were derived from Monte
Carlo (MC) simulations of energy deposition in water or proton fluence tallies in air. The
algorithm requires configuration data pertaining to the open beam and to the location of the
nozzle components relative to the target, which includes the central-axis absolute depth-dose
profile, DD(d), the effective source location and size, and the locations of the downstream
ends of the variable degrader and aperture. In addition, a library of range modulator designs
describing the thickness of each step and its relative fluence weight were available.
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The central-axis depth-dose profile used for the DD(d) term in equation (5) was derived
directly from MC calculations of the open beam’s absolute depth-dose profile as shown in
figure 4.
The effective source of the open beam was also characterized from MC simulation. Its
position served as the origin of the coordinate system within EYEDOSE. By locating the
effective source, SSD the distance from the effective source to the water phantom surface
was determined. In turn, SSD is used to calculate ωSAF via equations (8) and (9) and the
inverse square correction in equation (10).
The effective source size was determined from a second simulation and included a halfbeam block aperture, determined under the 4000 beam conditions, while tallying proton
fluence in air with a rectilinear mesh tally. A least-squares fit of an error function to the
proton fluence cross-field profile over a range of −0.5 cm < x < 0.5 cm adequately
characterized the Gaussian width of the open beam, σopen, which was back-projected to the
effective source location. Recall that σopen describes the inherent lateral spreading of the
beam and is included in the calculation of the propagated source size in equation (14).
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The locations of the beam-line components are important in modeling the penumbral width
and the location of the field edge. The locations of the downstream faces of these
components with respect to the open-beam effective source location were taken from the
values used in the MC model.
The reader is referred to Hong et al (1996) for further details of these and other parameters.
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Figure 1.
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Diagram of the calculation of β. The distances shown are z, the distance from the effective
source (S) to the point of interest (POI); zbld, the distance from S to the aperture; and κ, the
distance between the two rays cast from S to the aperture and from S to the POI, as
determined at the location of the aperture. Adapted from Koch (2006).
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Figure 2.

NIH-PA Author Manuscript

The Gaussian widths, σ, of pristine beams versus the reduced range for the 1500 (circle),
2000 (square), 3000 (diamond) and 4000 (triangle) Bragg peaks. The fourth-order spline
curve (solid line) was fit to the 4000 beam data and used in the analytical algorithm.
Adapted from Koch (2006).
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Figure 3.

A surface plot of the axially symmetric OAR parameter as a function of reduced range and
radial distance (r) from the central axis of the beam. Adapted from Koch (2006).
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Figure 4.
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The depth-dose profiles from calculations by MC (solid line), the analytical algorithm (open
circle) and ionization chamber measurements (crosses) adapted from Koch et al (2008).
Unmodulated beams with nominal ranges of 1.5 and 4 cm are indicated by the arrows
according to the labeling described in table 1; they respectively represent the worst and best
observed agreement among the unmodulated beams. The 4000 beam represents the openbeam condition described in the text and thus is more penetrating than modulated
therapeutic beams. The Monte Carlo-calculated depth-dose profile of the 4000 beam is
configuration data necessary for the analytical algorithm. The units shown are absolute dose
per monitor unit (D/MU) and water-equivalent depth (d). The MC and measured data were
adopted from Koch et al (2008).
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Figure 5.
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Depth-dose profiles for SOBPs from MC (solid line), ionization chamber measurements
(crosses) and analytical (open circles) calculations. The profiles here are for the (a) 2011, (b)
2020, (c) 3015 and (d) 3030 beams (see table 1). The units shown are absolute dose per
monitor unit (D/MU) and water-equivalent depth (d). MC and measured data were adopted
from Koch et al (2008).
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Figure 6.
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Radial profiles perpendicular to the beam axis at a depth of 0.5 cm from MC (solid line) and
EYEDOSE calculations (open circles) and at a depth of 2.4 cm from MC (dashed line) and
EYEDOSE calculations (open diamonds). All data shown consider the 3015 beam and have
been normalized to the dose (D) on the central axis versus the distance along the positive xaxis, perpendicular to the beam’s central axis. Note that the intensity of the cross-field
profiles changes slightly with distance from the central axis and depth, an effect modeled by
the analytical algorithm. Adopted from Koch (2006)
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Figure 7.

Results of 2D comparison of MC and EYEDOSE calculations, along the water-equivalent
depth, d, and radial distance, r, using the gamma function with 3% and 0.05 cm criteria.
These comparisons include the calculations performed on the flat-surfaced water phantom.
Overlaid on each subpart are the 20% (outermost), 50% (middle) and 90% (innermost)
isodose lines. All eight beams considered in this work are presented: (a) 1500, (b) 2000, (c)
3000, (d) 4000, (e) 2011, (f) 2020, (g) 3015, and (h) 3030 beams (see table 1). The MC data
were adopted from Koch et al (2008).
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Figure 8.
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Dose depth profiles of the 1500 and 4000 beams normalized to their respective peak dose
(D) values versus water-equivalent depth (d). The MC data for the 1500 and 4000 beams
shown in figure 4 are shown normalized to their peak dose values here (solid lines).
Contrasted with these results are the corresponding depth profiles obtained when all proton
histories that interact with any collimator component are terminated (dotted lines), with the
key differences occurring in the proximal region of the Bragg peak. Adopted from Koch
(2006)
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Figure 9.
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Differences observed in the 1500 (solid line) and 4000 (dotted line) beams, in terms of
percentage of the peak dose, for the corresponding profiles shown in figure 8 that were
generated from the simulation conditions including and excluding protons scattered by the
collimation system of the ocular nozzle. These differences are plotted versus the reduced
range, i.e. the ratio of the water-equivalent depth (d) to the water-equivalent range of the
beam to the distal 90% isodose level, R90. Adopted from Koch (2006)
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Figure 10.

Analytical dose calculations in an eye model, which was originally described by Koch et al
(2008), for the (a) 2011 and (b) 3030 beams in a 2D plane where x is perpendicular to the
beam axis and z is in the parallel to the beam axis, as represented in the room coordinate
system, i.e. isocenter was located at (0,0,0).
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Figure 11.

Results of 2D comparison of MC and analytical calculations using the gamma function with
3% and 0.5 mm criteria. These comparisons include calculations performed on the eye
model rotated clockwise 90° as shown in figure 10. Overlaid on each sub-figure are the 20%
(outermost), 50% (middle) and 90% (innermost) isodose lines. All eight beams considered
in this work are presented: (a) 1500, (b) 2000, (c) 3000, (d) 4000, (e) 2011, (f) 2020, (g)
3015 and (h) 3030 (see table 1). The MC data were adopted from Koch et al (2008).

NIH-PA Author Manuscript
Phys Med Biol. Author manuscript; available in PMC 2014 August 15.

NIH-PA Author Manuscript

NIH-PA Author Manuscript

1.5

2.0

3.0

4.0

2.0

2.0
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3.0

1500
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3000

4000

2011

2020

3015

3030

From Koch et al (2008).

a

Nominal range (cm)

Beam label

3.0

1.5

2.0

1.1

–

–

–

–

Nominal modulation width (cm)

2.0

2.3

0.93

1.5

0.9

0.9

0.9

0.9

Calibration depth (cm)

9.9

13.0

8.4

11.6

22.8

19.8

16.5

14.6

MCa (cGy/MU)

9.9

13.0

8.6

11.7

22.8

19.8

16.5

14.6

Analytical (A) (cGy/MU)

0.2

0.0

2.5

0.5

0.0

−0.4

0.3

0.2

(A-MC)/MC (%)

Features of the eight beams considered in this work. These beams and depths are similar to those used previously by Koch et al (2008). Each combination
of penetration range and modulation width in water was given a label for ease of reference. Shown in the three far right columns are the D/MU values
calculated in a previous work, the D/MU values calculated by the present analytical algorithm and their percent difference.
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15.5

20.4

30.5

40.5

18.7

18.0

28.6

28.6

1500

2000

3000

4000

2011

2020

3015

3030

28.6

28.5

18.6

18.7

40.5

30.5

20.4

15.5

BB (mm)

Adopted from Koch (2006).

MC (mm)

Beam

R90

28.6

14.4

18.0

11.0

4.4

4.4

4.4

4.4

MC (mm)

26.9

14.3

18.6

10.8

4.4

4.4

4.4

4.4

BB (mm)

R90 – P90

4.2

4.2

4.3

4.1

3.8

3.8

3.8

3.8

MC (mm)

4.2

4.2

4.1

4.1

3.8

3.8

3.8

3.8

BB (mm)

R80 – R20

our difference criterion of 0.5 mm are highlighted in bold.

difference in depth between the distal 20% to the distal 80% dose levels, R80 – R20. The values originating from the analytical algorithm that did not meet

Characteristics of the relative depth-dose profiles from simulations (MC), and broad-beam calculations (BB). Shown are the depths in water to the distal
90% dose level, R90; the difference in depth between the distal 90% and the proximal 90% dose levels, R90 – P90 (i.e. the modulation width); and the
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23.6
23.5
23.1

20

26

23.1

26
23.6

23.6

20

14

23.7

8

23.7

14

20

8

23.6
23.3

14

Adopted from Koch (2006).

3030

3015

23.6

23.2

20

8

23.5

14

2020

23.6

8

2011

MC (mm)

d (mm)

Beam

23.1

23.4

23.6

23.5

23.1

23.4

23.6

23.4

23.2

23.5

23.6

23.2

23.6

23.6

BB (mm)

90% to 90%

25.6

25.5

25.4

25.3

25.6

25.5

25.4

25.3

25.5

25.4

25.3

25.5

25.4

25.3

MC (mm)

25.7

25.6

25.5

25.3

25.7

25.6

25.5

25.3

25.5

25.5

25.3

25.5

25.5

25.3

BB (mm)

50% to 50%

1.6

1.3

1.1

1.0

1.6

1.3

1.1

1.0

1.4

1.2

1.1

1.4

1.2

1.1

MC (mm)

1.6

1.3

1.2

1.1

1.6

1.3

1.2

1.1

1.4

1.2

1.0

1.4

1.2

1.0

BB (mm)

Lateral 80% to 20%

Cross-field widths spanning the profile at the 90% to 90% and 50% to 50% dose levels, as normalized to the central axis, from the simulations (MC) and
broad-beam algorithm (BB) at several water-equivalent depths, d. Also shown are the 80% to 20% lateral penumbra widths. The measured field widths in
boldface type differed from simulations and calculations by 0.5 mm or more.
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